Literature DB >> 9843922

The locus of tumor necrosis factor-alpha action in lung inflammation.

S Smith1, S J Skerrett, E Y Chi, M Jonas, K Mohler, C B Wilson.   

Abstract

The pulmonary host response to infection and inflammation appears, at least in part, to be compartmentalized from the systemic host response. Tumor necrosis factor-alpha (TNF-alpha) has been implicated in lung inflammation and injury, but its site(s) of action has not been clearly defined. To investigate this, transgenic mice (surfactant apoprotein C promotor/soluble TNF receptor type II-Fc fusion protein ([SPCTNFRIIFc] mice) were generated in which TNF-alpha was selectively antagonized in the distal lung through tissue-specific expression of sTNFRIIFc, a soluble TNF inhibitor. The lung inflammatory response in these mice to pulmonary challenge with Micropolyspora faeni antigen or lipopolysaccharide (LPS) was compared with the response of wild-type mice, wild-type mice treated with recombinant sTNFRIIFc intravenously, and type I TNF-receptor knockout mice. Recruitment of polymorphonuclear leukocytes (PMN) to the lung after challenge with M. faeni antigen was essentially abolished in the TNFRI knockout mice and markedly reduced in the SPCTNFRIIFc mice. Wild-type mice given sTNFRIIFc intravenously in amounts resulting in lung concentrations similar to those in SPCTNFRIIFc mice also showed significantly reduced lung PMN recruitment, whereas those given doses that achieved such concentrations in the blood but low levels in the lung did not. In contrast, PMN recruitment to the lung following aerosol challenge with LPS was reduced significantly in the TNFRI knockout mice and in mice given high-dose sTNFRIIFc intravenously, but was not reduced significantly in SPCTNFRIIFc mice. Thus, inhibition of PMN recruitment in response to M. faeni antigen correlated largely with the extent of intrapulmonary inhibition of TNF-alpha, whereas the response to LPS correlated best with the extent of extrapulmonary inhibition of TNF-alpha. These studies indicate that TNF-alpha may act at different loci to mediate lung inflammation, with the site of action depending in part on the nature of the inflammatory stimulus, and that SPCTNFRIIFc mice provide a tool by which the locus of TNF action can be addressed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843922     DOI: 10.1165/ajrcmb.19.6.3146

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  11 in total

Review 1.  An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.

Authors:  Angela Panoskaltsis-Mortari; Matthias Griese; David K Madtes; John A Belperio; Imad Y Haddad; Rodney J Folz; Kenneth R Cooke
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

2.  The role of endothelial PI3Kgamma activity in neutrophil trafficking.

Authors:  Kamal D Puri; Teresa A Doggett; Ching-Yu Huang; Jason Douangpanya; Joel S Hayflick; Martin Turner; Josef Penninger; Thomas G Diacovo
Journal:  Blood       Date:  2005-03-15       Impact factor: 22.113

3.  Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP.

Authors:  Hogyoung Kim; Amarjit S Naura; Youssef Errami; Jihang Ju; A Hamid Boulares
Journal:  Mol Med       Date:  2011-05-13       Impact factor: 6.354

4.  TRAF1 regulates recruitment of lymphocytes and, to a lesser extent, neutrophils, myeloid dendritic cells and monocytes to the lung airways following lipopolysaccharide inhalation.

Authors:  Michiko K Oyoshi; Robert Barthel; Erdyni N Tsitsikov
Journal:  Immunology       Date:  2007-03       Impact factor: 7.397

5.  Pharmacological profile of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in models of airway inflammation.

Authors:  Alexandre Trifilieff; Christoph Walker; Thomas Keller; Georg Kottirsch; Ulf Neumann
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

6.  Local role for tumor necrosis factor alpha in the pulmonary inflammatory response to Mycobacterium tuberculosis infection.

Authors:  Sherilyn Smith; Denny Liggitt; Elizabeth Jeromsky; Xiaoxia Tan; Shawn J Skerrett; Christopher B Wilson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

7.  IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cells.

Authors:  Sara Saperstein; Linlin Chen; David Oakes; Gloria Pryhuber; Jacob Finkelstein
Journal:  J Interferon Cytokine Res       Date:  2009-05       Impact factor: 2.607

8.  Acrolein inhalation suppresses lipopolysaccharide-induced inflammatory cytokine production but does not affect acute airways neutrophilia.

Authors:  David Itiro Kasahara; Matthew E Poynter; Ziryan Othman; David Hemenway; Albert van der Vliet
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  Lung endothelial ADAM17 regulates the acute inflammatory response to lipopolysaccharide.

Authors:  Daniela Dreymueller; Christian Martin; Tanja Kogel; Jessica Pruessmeyer; Franz M Hess; Keisuke Horiuchi; Stefan Uhlig; Andreas Ludwig
Journal:  EMBO Mol Med       Date:  2012-02-24       Impact factor: 12.137

10.  Post-treatment with propofol inhibits inflammatory response in LPS-induced alveolar type II epithelial cells.

Authors:  Xilun Yang; Ling Ma
Journal:  Exp Ther Med       Date:  2022-01-31       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.